IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 310 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,000 | -22.2% | 150 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $9,000 | +28.6% | 150 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $7,000 | -22.2% | 150 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $9,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,000 | -10.0% | 150 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $10,000 | -16.7% | 150 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $12,000 | +50.0% | 150 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $8,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $8,000 | +33.3% | 150 | 0.0% | 0.00% | +33.3% |
| Q2 2018 | $6,000 | -14.3% | 150 | 0.0% | 0.00% | -25.0% |
| Q1 2018 | $7,000 | -12.5% | 150 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $8,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $8,000 | 0.0% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $8,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,529,838 | $404,393,000 | 11.39% |
| DOWLING & YAHNKE LLC | 676,379 | $41,888,000 | 5.27% |
| Opus Point Partners Management, LLC | 102,459 | $6,345,000 | 4.19% |
| WILLIAM HARRIS INVESTORS INC | 230,443 | $14,271,000 | 3.43% |
| PINNACLE ASSOCIATES LTD | 1,690,263 | $104,678,000 | 2.20% |
| MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ | 21,298 | $1,319,000 | 2.11% |
| Sonora Investment Management, LLC | 126,763 | $7,850,000 | 2.04% |
| Virtus ETF Advisers LLC | 10,447 | $647,000 | 1.78% |
| Apex Capital Management | 1,020,096 | $63,175,000 | 1.41% |
| PERKINS CAPITAL MANAGEMENT INC | 19,900 | $1,232,000 | 1.32% |